Phase 2 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older, of any gender.
- People who have been newly diagnosed with breast cancer confirmed by a biopsy.
- People who are able to read and understand Danish.
- People who are able to give written, informed consent to participate.
- People who are already scheduled to have a standard [¹⁸F]FDG PET/CT scan (a type of medical imaging scan) as part of their routine diagnostic care.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Women who are pregnant or breastfeeding.
- People who are unable to complete the imaging scan for any reason, such as claustrophobia (fear of enclosed spaces) or being unable to lie still for the full duration of the scan.
- People who are currently receiving cancer treatment for a different, separate cancer.
- People who have previously had an allergic reaction or sensitivity to the substance [⁶⁸Ga]Ga-FAP-2286, which is used in this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +45 53 57 45 55
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Number of patients with nodal and distant metastases detected by [⁶⁸Ga]Ga-FAP-2286 PET/CT at baseline (pre-treatment staging); Concordance of [⁶⁸Ga]Ga-FAP-2286 PET/CT with surgical pathology for axillary lymph node status after neoadjuvant therapy (restaging)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.